Stock CTMX CYTOMX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart CytomX Therapeutics, Inc.

Equities

CTMX

US23284F1057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-08 pm EDT 		Pre-market 07:16:14 pm
4.19 USD +2.95% Intraday chart for CytomX Therapeutics, Inc. 2.77 -33.89%
May. 08 Earnings Flash (CTMX) CYTOMX THERAPEUTICS Reports Q1 Revenue $41.5M MT
May. 07 CytomX Therapeutics, Inc. Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with Keytruda® (pembrolizumab) CI
e195813167f2df7.zsRK5AlHbdKPVSUgWFWnLfOKKAVvSBfFvAmK_M4EnDQ.jKoIrlATFYDiB1cXLALja7XFHFUiCWW37FzSjocwxXeAqwWMcT4c4L5hFQ~7d4c4a450e4480fff542a92e9c05f026
  1. Stock Market
  2. Equities
  3. CTMX Stock
  4. Charts CytomX Therapeutics, Inc.
  5. News Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW